@yalecancer.bsky.socialDr. David Schoenfeld cares for patients with #melanoma + #kidneycancer + joins #YaleCancerAnswers tonight at 7:30pm. Hear about the impact of #immunotherapy and how his lab is working to develop new immunotherapy therapies.
🎧Listen live #WNPR
đź’»Listen later #Spotify, #ApplePodcasts, #YouTube
@kidneycan.bsky.socialWhat role does genetics play in #KidneyCancer?
Join us October 28 for a FREE Town Hall exploring inherited cancer risk, genetic testing, and how emerging research could shape the future of kidney cancer care.
Register: https://kidneycan.org/genetics-kidney-cancer-family-risk
@kidneycan.bsky.socialWhy are we part of the Global Patient Survey on #KidneyCancer? When local efforts are coupled with a global approach, we can have the greatest impact on improving health equity and patient outcomes.
@ikccorg.bsky.socialThank you, Michael, Anne and Bryan, for being part of this journey and for the lasting impact you continue to make.
@actionkidneycancer.bsky.socialLast weekend we were delighted to attend the @ikccorg.bsky.social Global Kidney Cancer Summit in Prague and represent patients in the UK.
This was a great opportunity for us to meet more than 50 patient advocates, healthcare professionals and #kidneycancer experts from around the world.
@thecancersurvivorsclub.comPromising results for complex kidney cancer. A Phase 2 trial combining targeted radiation with surgery found 71% of patients remained recurrence-free after one year.
@actionkidneycancer.bsky.socialOur colleague recently represented #kidneycancer patients & families at the @Cancer52org Big Conversation. The event brought together the main stakeholders with lived experience, to engage with the latest developments in cancer research policy.
To read:
actionkidneycancer.org/the-big-canc...
@ikccorg.bsky.socialEvents like this create valuable opportunities to strengthen patient advocacy, exchange expertise and work towards better and more equitable kidney cancer care worldwide.
We are grateful for their support and commitment to the kidney cancer community.
@kidneycan.bsky.socialWhen Tracie’s husband was diagnosed with #kidneycancer, she decided to share her story and found connection, support, and a sense of community.
Looking for people who get it? Visit Kompass, a resource built with KCCure, KidneyCAN, KCA, NKF, & EisaiUS.
@ikccorg.bsky.socialThank you, Dr Ilbawi, for sharing your expertise and contributing to the Summit.
@actionkidneycancer.bsky.socialWe are promoting the @ikccorg.bsky.social GPS.
The more surveys completed the better the evidence we have to ensure we help #kidneycancer patients in the UK.
Patients and carers please help others by completing this survey, it will only take 15mins.
To survey:
actionkidneycancer.org/.../the-5th-...
@kidneycan.bsky.socialCould #KidneyCancer run in your family?
On Oct. 28, our panelists will discuss hereditary kidney cancer, when genetic testing may be considered, and what patients and families should know about inherited risk.
Register: https://kidneycan.org/genetics-kidney-cancer-family-risk
@ikccorg.bsky.socialWe are grateful to Minister Vojtěch for joining us and helping open this important gathering of the international kidney cancer community.
@ikccorg.bsky.socialA big thank you to everyone who participated, shared their knowledge and helped make the 2026 Summit a success.
@ikccorg.bsky.social🌍 Did you know that the Global Patient Survey on #kidneycancer is available in 18 languages, bringing together the experiences of people affected by kidney cancer from around the world?
đź’¬ Add your voice today and help make a difference: buff.ly/Mkj0pxs
@ikccorg.bsky.socialđź’š This World Mental Health Day, we recognise the emotional impact of kidney cancer on patients, carers and loved ones.
Mental health matters at every stage of the journey. Seeking support is important, and no one should have to face these challenges alone.
@kidneycan.bsky.socialClinical trials may be available at many different points in the #KidneyCancer treatment journey. Exploring what’s available can give you more information to discuss with your healthcare team.
@ikccorg.bsky.social🌍 Why are we part of the Global Patient Survey on #kidneycancer?
Because when local efforts are combined with a global approach, we can have the greatest impact on improving health equity and patient outcomes for people affected by kidney cancer: buff.ly/Mkj0pxs
@oncoalert.bsky.socialAfter IO, the road in #RCC gets murky 🌫️
So our good friends the UROMIGOS (Dr. Brian Rini & Dr. Tom Powles) asked global experts to score each option, from 0 (avoid) to 3 (SOC).
Where's the consensus, and where's the split? 🔥
Dr. Laurence Albiges walks us through it 👇
@kidneycan.bsky.socialCould #KidneyCancer run in your family?
Join us October 28 for our FREE Town Hall, Genetics and Kidney Cancer: From Family Risk to the Future of Patient Care.
Register: https://kidneycan.org/genetics-kidney-cancer-family-risk
